uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
The antipsychotic drug trifluoperazine inhibits DNA repair and sensitizes non-small cell lung carcinoma cells to DNA double-strand break-induced cell death
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology, Biomedical Radiation Sciences. (BMS)
Show others and affiliations
2007 (English)In: Molecular Cancer Therapeutics, ISSN 1535-7163, E-ISSN 1538-8514, Vol. 6, no 8, 2303-2309 p.Article in journal (Refereed) Published
Abstract [en]

Trifluoperazine (TFP), a member of the phenothiazine class of antipsychotic drugs, has been shown to augment the cytotoxicity of the DNA-damaging agent bleomycin. In the present study, we investigated the effect of trifluoperazine on (a) survival of bleomycin-treated human non-small cell lung carcinoma U1810 cells, (b) induction and repair of bleomycin-induced DNA strand breaks, and (c) nonhomologous end-joining (NHEJ), the major DNA double-strand break (DSB) repair pathway in mammalian cells. By using a clonogenic survival assay, we show here that concomitant administration of trifluoperazine at a subtoxic concentration enhances the cytotoxicity of bleomycin. Moreover, trifluoperazine also increases the longevity of bleomycin-induced DNA strand breaks in U1810 cells, as shown by both comet assay and fraction of activity released (FAR)-assay. This action seems to be related to suppression of cellular DNA DSB repair activities because NHEJ-mediated rejoining of DSBs occurs with significantly lower efficiency in the presence of trifluoperazine. We propose that TFP might be capable of inhibiting one or more elements of the DNA DSB repair machinery, thereby increasing the cytotoxicity of bleomycin in lung cancer cells.

Place, publisher, year, edition, pages
2007. Vol. 6, no 8, 2303-2309 p.
Keyword [en]
Antipsychotic Agents/*pharmacology, Bleomycin/pharmacology, Carcinoma; Non-Small-Cell Lung/*pathology, Cell Death/drug effects, Cell Line; Tumor, DNA Breaks; Double-Stranded/*drug effects, DNA Repair/*drug effects, Drug Synergism, Humans, Lung Neoplasms/*pathology, Recombination; Genetic/drug effects, Trifluoperazine/*pharmacology, Tumor Stem Cell Assay
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-15056DOI: 10.1158/1535-7163.MCT-06-0402ISI: 000248663000017PubMedID: 17699725OAI: oai:DiVA.org:uu-15056DiVA: diva2:42827
Available from: 2008-02-04 Created: 2008-02-04 Last updated: 2011-01-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=17699725&dopt=Citation
By organisation
Biomedical Radiation Sciences
In the same journal
Molecular Cancer Therapeutics
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 175 hits
ReferencesLink to record
Permanent link

Direct link